![Felix Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Felix Baker
Président chez
BICYCLE THERAPEUTICS PLC
Fortune : 48 M $ au 31/08/2026
Profil
Dr. Felix J.
Baker is an Independent Non-Executive Director at BeOne Medicines Ltd., a Lead Independent Director at Kiniksa Pharmaceuticals International Plc, a Non-Executive Chairman at Bicycle Therapeutics Plc, a Chairman at Kymera Therapeutics, Inc., a Lead Independent Director at Kiniksa Pharmaceuticals Ltd., an Independent Director at Kodiak Sciences, Inc., a Managing Member at Baker Bros.
Advisors LP, a Co-Managing Partner at Baker Bros.
Advisors GP LLC, a Manager at Fbb2 LLC and a Partner at FBB Associates.
He is on the Board of Directors at BeOne Medicines Ltd., Kiniksa Pharmaceuticals International Plc, Kiniksa Pharmaceuticals Ltd., Kodiak Sciences, Inc., Kiniksa Pharmaceuticals Corp., N-Power Medicine, Inc. and Memorial Sloan Kettering Cancer Center.
Dr. Baker was previously employed as an Independent Director by IGM Biosciences, Inc., an Independent Director by Alexion Pharmaceuticals, Inc., a Chairman by Talis Biomedical Corp., an Independent Director by Genomic Health, Inc., an Independent Director by Ardea Biosciences, Inc., a Chairman by Seagen, Inc., a Chairman by Synageva BioPharma Corp., and an Owner by VaxGen, Inc. He also served on the board at Trimeris, Inc., ConjuChem Biotechnologies, Inc. /Old/, Neurogen Corp., ConjuChem, Inc., AnorMED, Inc., Aquinox Pharmaceuticals, Inc., ConjuChem Biotechnologies, Inc., Presidio Pharmaceuticals, Inc. and SlipChip Corp.
He received his undergraduate degree from Stanford University and a doctorate degree from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics 0,14 % | 30/06/2026 | 281 190 ( 0,14 % ) | 35 M $ | 31/08/2026 |
BEONE MEDICINES LTD. 0,02 % | 14/09/2026 | 311 142 ( 0,02 % ) | 9 M $ | 31/08/2026 |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders 0,06 % | 29/05/2026 | 102 876 ( 0,06 % ) | 3 M $ | 31/08/2026 |
0,06 % | 06/04/2026 | 27 386 ( 0,06 % ) | 2 M $ | 31/08/2026 |
| 13/04/2026 | 16 400 ( 0,04 % ) | 67 732 $ | 31/08/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Felix Baker
| Sociétés | Poste | Début |
|---|---|---|
| KODIAK SCIENCES INC. | Directeur/Membre du Conseil | 01/09/2015 |
| KYMERA THERAPEUTICS, INC. | Président | 24/06/2026 |
| BICYCLE THERAPEUTICS PLC | Président | 17/06/2025 |
| BEIGENE LTD | Directeur/Membre du Conseil | 11/06/2026 |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities. | Fondateur | 01/01/2000 |
Fbb2 LLC | Corporate Officer/Principal | - |
N-POWER MEDICINE, INC.
 N-POWER MEDICINE, INC. BiotechnologyHealth Technology Operates as a clinical research and drug development platform company | Directeur/Membre du Conseil | - |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Directeur/Membre du Conseil | - |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Felix Baker
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Felix Baker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
30
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 30 |
|---|---|
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops metal based therapeutics | Health Technology |
ConjuChem, Inc.
 ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs or pharmaceutical substances to treat Type 2 diabetes or other diagnostic substances | Health Technology |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities. | Finance |
Genomic Health, Inc.
 Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
ConjuChem Biotechnologies, Inc. /Old/
 ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Health Technology |
Fbb2 LLC | |
Baker Bros. Advisors GP LLC | |
SlipChip Corp. | |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FBB Associates | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops small-molecule antiviral therapeutics | Health Technology |
ConjuChem Biotechnologies, Inc.
 ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Health Technology |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Kodiak Sciences, Inc.
 Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
Talis Biomedical Corp.
 Talis Biomedical Corp. Medical SpecialtiesHealth Technology Manufactures testing and diagnostic instruments for infectious diseases | Health Technology |
N-POWER MEDICINE, INC.
N-POWER MEDICINE, INC. BiotechnologyHealth Technology Operates as a clinical research and drug development platform company | Health Technology |
